Results 151 to 160 of about 159,674 (308)
Genotoxic Activity of <i>Cerastes cerastes</i> Viper Venom Using Alkaline Single-Cell Gel Electrophoresis. [PDF]
Ouhemmou Z +8 more
europepmc +1 more source
ABSTRACT Autism spectrum disorder (ASD) is frequently associated with motor difficulties that may affect daily functioning, participation in physical activity, and developmental outcomes. Although motor impairments have been widely reported in this population, comparative evidence against typically developing (TD) peers remains fragmented across ...
Nerea Blanco‐Martínez +4 more
wiley +1 more source
The genomic origins and evolutionary path to a key innovation in the world's most venomous snakes. [PDF]
van Thiel J +4 more
europepmc +1 more source
Venoms, venomous animals and anti-venomous serum-therapeutics
A. Calmette, E. E. Austen
openaire +6 more sources
The beneficial effects of honeybee-venom serum on facial wrinkles in humans
Sang Mi Han,1 In Phyo Hong,1 Soon Ok Woo,1 Sung Nam Chun,2 Kwan Kyu Park,3 Young Mee Nicholls,4 Sok Cheon Pak5 1Department of Agricultural Biology, National Academy of Agricultural Science, Wanju, 2Dong Sung Pharmaceuticals Co Ltd, Seoul, 3Department of
Woo SO +6 more
core
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen +7 more
wiley +1 more source
Effects of graded dietary raw bee venom inclusion on growth, immunity, and disease resistance in Nile tilapia (Oreochromis niloticus). [PDF]
Reda RM +7 more
europepmc +1 more source
Trimucytin is a powerful platelet aggregation inducer isolated from the venom of Taiwan habu snake (Trimeresurus mucrosquamatus). In this study, we found that the snake venom protein, crovidisin, which prevents collagen -platelet interaction through its ...
HUANG, TUR-FU, 黃德富
core
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley +1 more source
Proteomic characterization of <i>Tityus championi</i> venom and recombinant expression of its major neurotoxin. [PDF]
Muñoz-Agames MDC +8 more
europepmc +1 more source

